Oncohematology Summit

The QIAGEN Oncohematology Summit – September 15 and 16, 2021 – brought together global oncohematology experts to discuss their experience and insights in oncohematology testing and blood cancer clinical research. Over two days, our speakers discussed the unique challenges faced by researchers and clinicians in this complex field and how to overcome them. Attendees got the latest on developments in oncohematology testing, optimized testing workflows, key European regulatory changes, relevant blood cancer clinical research and how to help improve patient care.

The event was free to attend and is not to be missed if you work in oncohematology diagnostic testing or blood cancer clinical research.

The presentations are available to view on demand for a short time. You need to register to watch the on-demand recordings.

Watch the video

Program

Day 1, September 15, 2021
14.00–14.45 CET Keynote lecture	Evolution and future of oncohematology testing Prof. Dr. Martin C. Müller, CEO, Institute for Hematology and Oncology, Germany
14.45–15.30 CET Presentation	Improved leukemia patient care with molecular detection and quantification Anna Tarasewicz, Haematology & Blood Transfusion BSUH and Munyoro Guvamatanga, Princess Elizabeth Hospital Guernsey, UK
15.30–15.45 CET	Break
15.45–16.30 CET Presentation	Implementation of a comprehensive genomic profiling approach for myeloid neoplasms Dr. Vincent Funari, NeoGenomics, USA
16.30–17.15 CET Presentation	Reality and challenges of oncohematology testing Dr. Susanna Akiki, Hamad Medical Corporation, Qatar

Day 2, September 16, 2021
15.00–15.45 CET Presentation	The new EU IVD Regulation Volker Franzen, Senior Director Regulatory and Governmental Affairs, QIAGEN, Germany
15.45–16.30 CET Presentation	Overcoming challenges of NGS panel workflows for myeloid neoplasms applications Krishna Amin, Global Product Manager Targeted Genomics, QIAGEN, USA
16.30–16.45 CET	Break
16.45–17.45 CET Expert panel	Evolution and future of oncohematology testing Dr. Susanna Akiki (Qatar), Prof. Dr. Susan Branford (Australia), Prof. Dr. Ross Levine (USA) and Prof. Dr. Martin C. Müller (Germany); Moderator: Davide Manissero, Chief Medical Officer, QIAGEN, UK

Speakers

Registration

Need some help?

Contact our events team with any questions about the Oncohematology Summit

Get in touch

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit handbook or user manual. QIAGEN kit handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services or your local distributor.